Cargando…

Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy

The paradigm of drug delivery via particulate formulations is one of the leading ideas that enable overcoming limitations of traditional chemotherapeutic agents. The trend toward more complex multifunctional drug carriers is well-traced in the literature. Nowadays, the prospectiveness of stimuli-res...

Descripción completa

Detalles Bibliográficos
Autores principales: Verkhovskii, Roman A., Ivanov, Alexey N., Lengert, Ekaterina V., Tulyakova, Ksenia A., Shilyagina, Natalia Yu., Ermakov, Alexey V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222897/
https://www.ncbi.nlm.nih.gov/pubmed/37242807
http://dx.doi.org/10.3390/pharmaceutics15051566
_version_ 1785049810322063360
author Verkhovskii, Roman A.
Ivanov, Alexey N.
Lengert, Ekaterina V.
Tulyakova, Ksenia A.
Shilyagina, Natalia Yu.
Ermakov, Alexey V.
author_facet Verkhovskii, Roman A.
Ivanov, Alexey N.
Lengert, Ekaterina V.
Tulyakova, Ksenia A.
Shilyagina, Natalia Yu.
Ermakov, Alexey V.
author_sort Verkhovskii, Roman A.
collection PubMed
description The paradigm of drug delivery via particulate formulations is one of the leading ideas that enable overcoming limitations of traditional chemotherapeutic agents. The trend toward more complex multifunctional drug carriers is well-traced in the literature. Nowadays, the prospectiveness of stimuli-responsive systems capable of controlled cargo release in the lesion nidus is widely accepted. Both endogenous and exogenous stimuli are employed for this purpose; however, endogenous pH is the most common trigger. Unfortunately, scientists encounter multiple challenges on the way to the implementation of this idea related to the vehicles’ accumulation in off-target tissues, their immunogenicity, the complexity of drug delivery to intracellular targets, and finally, the difficulties in the fabrication of carriers matching all imposed requirements. Here, we discuss fundamental strategies for pH-responsive drug delivery, as well as limitations related to such carriers’ application, and reveal the main problems, weaknesses, and reasons for poor clinical results. Moreover, we attempted to formulate the profiles of an “ideal” drug carrier in the frame of different strategies drawing on the example of metal-comprising materials and considered recently published studies through the lens of these profiles. We believe that this approach will facilitate the formulation of the main challenges facing researchers and the identification of the most promising trends in technology development.
format Online
Article
Text
id pubmed-10222897
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102228972023-05-28 Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy Verkhovskii, Roman A. Ivanov, Alexey N. Lengert, Ekaterina V. Tulyakova, Ksenia A. Shilyagina, Natalia Yu. Ermakov, Alexey V. Pharmaceutics Review The paradigm of drug delivery via particulate formulations is one of the leading ideas that enable overcoming limitations of traditional chemotherapeutic agents. The trend toward more complex multifunctional drug carriers is well-traced in the literature. Nowadays, the prospectiveness of stimuli-responsive systems capable of controlled cargo release in the lesion nidus is widely accepted. Both endogenous and exogenous stimuli are employed for this purpose; however, endogenous pH is the most common trigger. Unfortunately, scientists encounter multiple challenges on the way to the implementation of this idea related to the vehicles’ accumulation in off-target tissues, their immunogenicity, the complexity of drug delivery to intracellular targets, and finally, the difficulties in the fabrication of carriers matching all imposed requirements. Here, we discuss fundamental strategies for pH-responsive drug delivery, as well as limitations related to such carriers’ application, and reveal the main problems, weaknesses, and reasons for poor clinical results. Moreover, we attempted to formulate the profiles of an “ideal” drug carrier in the frame of different strategies drawing on the example of metal-comprising materials and considered recently published studies through the lens of these profiles. We believe that this approach will facilitate the formulation of the main challenges facing researchers and the identification of the most promising trends in technology development. MDPI 2023-05-22 /pmc/articles/PMC10222897/ /pubmed/37242807 http://dx.doi.org/10.3390/pharmaceutics15051566 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Verkhovskii, Roman A.
Ivanov, Alexey N.
Lengert, Ekaterina V.
Tulyakova, Ksenia A.
Shilyagina, Natalia Yu.
Ermakov, Alexey V.
Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy
title Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy
title_full Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy
title_fullStr Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy
title_full_unstemmed Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy
title_short Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy
title_sort current principles, challenges, and new metrics in ph-responsive drug delivery systems for systemic cancer therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222897/
https://www.ncbi.nlm.nih.gov/pubmed/37242807
http://dx.doi.org/10.3390/pharmaceutics15051566
work_keys_str_mv AT verkhovskiiromana currentprincipleschallengesandnewmetricsinphresponsivedrugdeliverysystemsforsystemiccancertherapy
AT ivanovalexeyn currentprincipleschallengesandnewmetricsinphresponsivedrugdeliverysystemsforsystemiccancertherapy
AT lengertekaterinav currentprincipleschallengesandnewmetricsinphresponsivedrugdeliverysystemsforsystemiccancertherapy
AT tulyakovakseniaa currentprincipleschallengesandnewmetricsinphresponsivedrugdeliverysystemsforsystemiccancertherapy
AT shilyaginanataliayu currentprincipleschallengesandnewmetricsinphresponsivedrugdeliverysystemsforsystemiccancertherapy
AT ermakovalexeyv currentprincipleschallengesandnewmetricsinphresponsivedrugdeliverysystemsforsystemiccancertherapy